SPAC Drugs Made In America Acquisition II Corp. closes $500M IPO; $500M in trust

Drugs Made In America Acquisition II Corp.

Priced and closed IPO of 50M units at $10/unit for gross proceeds of $500M.
Concurrent private placement of 1.2M units ($12M) to sponsor and Cantor Fitzgerald.
Net proceeds of $500M deposited into trust account for public shareholders.
Units trade on Nasdaq under DMIIU; ordinary shares and rights to trade separately later.
Appointed Catherine Do, G. Sridhar Prasad, Myron W. Shulgan to board and committees.

item 1.01item 3.02item 5.02item 5.03item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.